BCAX vs DOV · $1.51B cap vs P/E 27, rev $4.24B
Bicara Therapeutics Inc. Common Stock (BCAX) versus Dover Corporation (DOV) — a side-by-side from cached financials, not a winner call.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
BCAX does not have a complete income-statement cache yet.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
BCAX currently screens at market cap $1.51B. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Not investment advice. Open the BCAX and DOV stock pages for the full models.
Not investment advice.